Trial Profile
Transcutaneous lisuride therapy of Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Lisuride (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 25 Oct 2005 New trial record.